Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis

Eitemau Tebyg

• The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies
  gan: Kimaro, Godfather Dickson, et al.
  Cyhoeddwyd: (2017)
• The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
  gan: Godfather Dickson Kimaro, et al.
  Cyhoeddwyd: (2017-01-01)
• Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
  gan: Shiri, Tinevimbo, et al.
  Cyhoeddwyd: (2020)
• Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
  gan: Chen, Tao, et al.
  Cyhoeddwyd: (2019)
• The acceptability of integrated healthcare services for HIV and non-communicable diseases: experiences from patients and healthcare workers in Tanzania
  gan: Elizabeth H. Shayo, et al.
  Cyhoeddwyd: (2022-05-01)